	Artificial Intelligence Design for Race-Based Prostate Cancer Stage Classification With Multilayer Perceptron: Feature Selection Optimization Approach. JMIR Form Res Mulia A, Agustriawan D, Overbeek M, Widjaja M, Kurniawan V, Syechlo J, Ahmad MI, Sathipati SY, Kurubanjerdjit N. PMID: 41989963 [PubMed - indexed for MEDLINE]
	Clinical Outcomes in Bacillus Calmette-GuÃ©rin-Exposed Non-Muscle-Invasive Bladder Cancer. JAMA Netw Open Giatsoglou M, Chatzistavrou D, Sopczynski JM, Feng G, Li R. PMID: 41989781 [PubMed - indexed for MEDLINE]
	Ongoing and completed clinical trials on prostate cancer screening using MRI. Eur Radiol Wallström J, Jäderling F, Langkilde F, Arnsrud Godtman R, Bratt O, Thimansson E. PMID: 41989465 [PubMed - as supplied by publisher]
	Primary Prostatic Alveolar Rhabdomyosarcoma in Adult, a Diagnostic Pitfall: Report of an Extremely Rare Tumor. Int J Surg Pathol Mitra S, Choube A, Ratnaparkhi C, Pande S. PMID: 41989357 [PubMed - as supplied by publisher]
	Micro-ultrasonography- vs MRI-targeted biopsy in prostate cancer: Updated systematic review and meta-analysis. BJU Int Micheleto JPC, Suzuki TÁ, Santos LA, Sales LP, Lopes RI, Martins BM, Aguiar Melão BVL, Cordeiro MD, Sharour W, Shabana W, Nahas WC, Ribeiro Filho LA, Suartz CV. PMID: 41989063 [PubMed - as supplied by publisher]
	Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617. Cancer Gerke MB, Marra A, Liu Y, Bedmutha A, Brown JT, Nazha B, Berchuck JE, Parikh RB, Ahmed S, Ciuro JA, Hartman C, McClintock GR, Caulfield S, Kucuk O, Carthon BC, Schuster DM, Muzahir S, Bilen MA. PMID: 41989013 [PubMed - indexed for MEDLINE]
	Clinically Localized Prostate Cancer: AUA/ASTRO Guideline Amendment (2026). J Urol Eastham JA, Barocas DA, Chu CE, Morgans AK, Rodrigues G, Kirkby E, Pak LJ, Patel S. PMID: 41988960 [PubMed - as supplied by publisher]
	Urine-Based FTIR Spectroscopy and Machine Learning Enable Non-Invasive Kidney Cancer Detection. J Biophotonics Mitura P, Odrzywolski A, Szyszkowska O, Gumbarewicz E, Kuliniec I, Godzisz M, Jad, Depciuch J. PMID: 41988812 [PubMed - indexed for MEDLINE]
	Evolving Treatments and Resistance Mechanisms in Prostate Cancer Therapeutics. ACS Pharmacol Transl Sci Sai Rishma Reddy GSV, Kumar A, Sharma NK, Samanta K, Pramanik D, Karampudi NBR, Kar P. PMID: 41988377 [PubMed]
	A case report of cerebral vasculitis induced by ipilimumab with nivolumab in a patient with metastatic renal cell carcinoma. Front Immunol Palacka P, Málek T, Makovník M, Felediová R, Rychlý B, Kolníková G. PMID: 41988182 [PubMed - indexed for MEDLINE]
	Primary healthcare-friendly prostate cancer prediction model using routine clinical parameters: a multicenter study. Front Oncol Chen M, Li T, Yang S, Zhou Y, Lin H, Lan J, Zhang X, Yang X, Zhou J, Lyu G. PMID: 41988122 [PubMed]
	Micro-ultrasound tissue echogenicity predicts prostate cancer grade. BJUI Compass Corona AE, Luca D, Sohrabi KK, Grunden K, Chen W, Sarmadian PJ, Walsh KJ, Kwan L, Miao Q, Sung K, Brisbane WG. PMID: 41987882 [PubMed]
	Rezvilutamide plus docetaxel in chemotherapy-naive metastatic castration-resistant prostate cancer patients after progression on abiraterone: A multi-centre, open-label, phase II trial. Clin Transl Med Liu Z, Chen B, Dai T, Jiang S, Luo H, Liao H, Yu D, Chen Z, Zhang D, Li Z, Zhang Z, Bai H, Liu F, Lin J, Wang Y, Feng P, Wei Q. PMID: 41987598 [PubMed - indexed for MEDLINE]
	Kidney disease and determinants of health as correlates to primary bone cancer: a cross-sectional US population-based study. BMC Nephrol Shouman M, Jaffa AA, Jaffa MA. PMID: 41987130 [PubMed - as supplied by publisher]
	Lymphedema and self-reported swelling among Danish survivors of prostate cancer - prevalence, clinical associations and functional implications. Support Care Cancer Levinsen AKG, Ammitzbøll G, Kjaer TK, Borre M, Larsen SB, Dalton SO. PMID: 41986761 [PubMed - indexed for MEDLINE]
	Predictive value of early PSMA upregulation for the response to enzalutamideâ€‰Â±â€‰(177)Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial. Nat Cancer Emmett L, Swiha M, Papa N, Subramaniam S, Crumbaker M, Joshua AM, Nguyen A, Weickhardt A, Lee ST, Ng S, Francis RJ, Goh JC, Pattison DA, Pathmanandavel S, Hope T, Ayati N, Hofman MS, Sandhu S, Niu C, Martin AJ, Thomas H, Stockler MR, Davis ID, Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group. PMID: 41986500 [PubMed - as supplied by publisher]
	Treatments on the Horizon for Men with Advanced Prostate Cancer. Urol Clin North Am Ehrlich MI, Gejman RS, Bernstein E, Stein MN. PMID: 41986027 [PubMed - indexed for MEDLINE]
	Systemic Treatments of Castration-Resistant Prostate Cancer. Urol Clin North Am Desai AN, Fleyshman M, Lall N, Saraiya B. PMID: 41986026 [PubMed - indexed for MEDLINE]
	Recent Advances in Understanding the Biology of Castration-Resistant Prostate Cancer. Urol Clin North Am Lluís D, Cheng W, Piulats JM, Heras L, Aytes Á, Kruithof de Julio M. PMID: 41986025 [PubMed - indexed for MEDLINE]
	Radiotherapy in Men with De Novo Metastatic Prostate Cancer. Urol Clin North Am Messing I, Rao YJ, Goyal S. PMID: 41986024 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 177549

Page 1 of 8878



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy